| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.5 |